The first study, conducted in male mice, found that exenatide treatment did not significantly alter morphine-conditioned place preference, intravenous self-administration of the short-acting synthetic opioid remifentanil, morphine-induced locomotor activity, or the somatic signs of morphine withdrawal.163 Additionally, exenatide did not significantly affect the analgesic efficacy of morphine in the hot-plate test.163 Notably, remifentanil self-administration was comparable to or increased in mice lacking central nervous system GLP-1 receptors relative to wild-type controls.163 It is important to acknowledge that the association between GLP-1RAs and suicidal behavior has not been sufficiently studied
Phase 2 data showed 24.2% average weight loss at 48 weeks
GLP-1 Boost helps restore natural hunger cues while gently lifting energy and motivation, making it easier to snack less and stay on track.* SUPPORT WEIGHT MANAGEMENT FOR LONG-TERM SUCCESS: Unlike crash diet pills, injections, or trendy supplements, GLP-1 Boost is designed for daily use
The postprandial actions of GLP-1 receptor agonists: The missing link for cardiovascular and kidney protection in type 2 diabetes
B., Eringa, E